物质信息
ID:177692
名称和标识
IUPAC传统名
nitro blue tetrazolium(2+) dichloride
IUPAC标准名
2-(2-methoxy-4-{3-methoxy-4-[3-(4-nitrophenyl)-5-phenyl-3H-1,2λ5,3,4-tetrazol-2-ylium-2-yl]phenyl}phenyl)-3-(4-nitrophenyl)-5-phenyl-3H-1,2λ5,3,4-tetrazol-2-ylium dichloride
别名
Nitro Blue TetrazoliumNitrotetrazolium Blue Chloride
化合物性质
安全信息
GHS警示词
Warning
个人保护装置
dust mask type N95 (US), Eyeshields, Gloves
安全公开号
26
GHS危险声明
H319
GHS危险品标识
急性毒性（口服，皮肤接触，吸入），类别4
皮肤刺激，类别2
眼刺激，类别2
皮肤过敏，类别1
特定目标器官毒性 -一次接触，类别3
保存温度
2-8°C
欧盟危险性物质标志
有害性 (Xn)GHS警示性声明
P305+P351+P338
危险公开号
22-36
德国WGK号
3
理化性质
外观
tablet
描述信息
Quantity
Contains 10 mg substrate per tablet.
Specificity
Nitro Blue Tetrazolium is used in conjunction with the alkaline phosphatase substrate 5-Bromo-4-Chloro-3-Indolyl Phosphate (BCIP) Tablets (Sigma Product No. B0274) in immunoblotting and immunohistological staining procedures. This substrate system produces an insoluble end product that is blue-purple in color and can be observed visually.
Contains 10 mg substrate per tablet.
Specificity
Nitro Blue Tetrazolium is used in conjunction with the alkaline phosphatase substrate 5-Bromo-4-Chloro-3-Indolyl Phosphate (BCIP) Tablets (Sigma Product No. B0274) in immunoblotting and immunohistological staining procedures. This substrate system produces an insoluble end product that is blue-purple in color and can be observed visually.
分子图谱
暂无数据
点击上传数据
参考文献
暂无数据
点击上传数据